SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001564590-22-002405
Filing Date
2022-01-26
Accepted
2022-01-26 09:00:55
Documents
1
Effectiveness Date
2022-01-26

Document Format Files

Seq Description Document Type Size
1 S-8 POS odt-s8pos.htm S-8 POS 24500
  Complete submission text file 0001564590-22-002405.txt   25725
Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-234529 | Film No.: 22555939
SIC: 2834 Pharmaceutical Preparations